TipRanks
Adaptive Biotechnologies Corp (DE:1HM)
FRANKFURT:1HM
Germany Market
1HM
Adaptive Biotechnologies
RESEARCH TOOLSreports

Adaptive Biotechnologies (1HM) Income Statement

3 Followers

Adaptive Biotechnologies Income Statement

Last quarter (Q2 2026), Adaptive Biotechnologies's total revenue was $71.55M, an increase of 21.53% from the same quarter last year. In Q2, Adaptive Biotechnologies's net income was $-39.79M. See Adaptive Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 276.98M$ 178.96M$ 170.28M$ 185.31M$ 154.34M
Gross Profit
$ 205.62M$ 106.88M$ 94.72M$ 127.40M$ 105.04M
Operating Expenses
$ 262.74M$ 269.43M$ 321.76M$ 327.58M$ 314.01M
Depreciation and Amortization
$ 17.83M$ 19.26M$ 22.23M$ 20.92M$ 13.95M
EBITDA
$ -29.85M$ -128.76M$ -189.27M$ -175.21M$ -193.34M
Operating Income
$ -57.12M$ -162.55M$ -227.03M$ -200.19M$ -208.97M
Other Income/Expenses
$ -2.33M$ 2.95M$ 1.73M$ -182.00K$ 1.67M
Pretax Income
$ -59.46M$ -159.59M$ -225.30M$ -200.37M$ -207.30M
Net Income
$ -59.50M$ -159.49M$ -225.25M$ -200.19M$ -207.28M
Per Share Metrics
Basic EPS
$ -0.39$ -1.08$ -1.56$ -1.00$ -1.46
Diluted EPS
$ -0.39$ -1.08$ -1.56$ -1.00$ -1.46
Weighted Average Shares Outstanding
 151.72M 147.10M 144.38M 142.52M 140.35M
Weighted Average Shares Outstanding (Diluted)
 151.72M 147.10M 144.38M 142.52M 140.35M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History